Journal article
Novel developments in angiogenesis cancer therapy
Abstract
A greater understanding of the factors and pathways controlling angiogenesis in tumours has allowed the development of a number of agents that selectively inhibit the pathways mediating that activity. The results to date of clinical trials with such agents and future research opportunities are reviewed.
Authors
Hirte HW
Journal
Current Oncology, Vol. 16, No. 3, pp. 50–54
Publisher
MDPI
Publication Date
May 2009
DOI
10.3747/co.v16i3.444
ISSN
1198-0052